Thanks Diogenese. Always enjoy your valuable input.
I wasn’t trying to marginalize the importance of talnode si or cathode additives. I think they both sound very promising and will feature in the revenue stream in the not too distant future.
I was simply questioning the short term strategy and looking for more comfort since Talga is pre-revenue (commercialization near term) with a relatively short cash runway if it would be more beneficial to focus on the lower hanging fruit being everything to do with talnode C and biding our time until we get permits , offtakes and funding sorted.
Unfortunately , I don’t think we have enough information about the talnode Si or cathode additives financials/commercialization plans, nor do we have the breakdown of resources (staff , time, budget) and costs (of running those center of excellence) split by the respective products. I just wonder if there is an opportunity to tighten the ship in the near term.
It’s the internet damn it - let me challenge the status quo on a forum